Paper42404005
An Evolutionary Research Framework for the Tumor Microenvironment in Gastric Cancer.
Chen Z and 3 others. J Inflamm Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. An Evolutionary Research Framework for the Tumor Microenvironment in Gastric Cancer. Papers, record 42404005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42404005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36596787 | Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer. | Nat Commun | 2023 | https://conductscience.org/library/papers/36596787 | PubMed |
| 2 | 39575245 | Immunotherapy plus chemotherapy versus chemotherapy alone in the first-line treatment for advanced gastric cancer/gastroesophageal junction cancer: a real-world retrospective study. | Front Immunol | 2024 | https://conductscience.org/library/papers/39575245 | PubMed |
| 3 | 33081836 | Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway. | J Exp Clin Cancer Res | 2020 | https://conductscience.org/library/papers/33081836 | PubMed |
| 4 | 39377861 | Integrative analysis of multiple cell death model for precise prognosis and drug response prediction in gastric cancer. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39377861 | PubMed |
| 5 | 38881867 | Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38881867 | PubMed |
| 6 | 25079317 | Comprehensive molecular characterization of gastric adenocarcinoma. | Nature | 2014 | https://conductscience.org/library/papers/25079317 | PubMed |
| 7 | 39990209 | Histone lactylation-driven B7-H3 expression promotes tumor immune evasion. | Theranostics | 2025 | https://conductscience.org/library/papers/39990209 | PubMed |
| 8 | 40154487 | Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. | Cancer Cell | 2025 | https://conductscience.org/library/papers/40154487 | PubMed |
| 9 | 37984993 | Metabolic and immune-related gene signatures: Predictive stratification and prognostic implications in gastric cancer. | J Gene Med | 2024 | https://conductscience.org/library/papers/37984993 | PubMed |
| 10 | 39895920 | Non-coding RNA in the Regulation of Gastric Cancer Tumorigenesis: Focus on microRNAs and Exosomal microRNAs. | Int J Mol Cell Med | 2024 | https://conductscience.org/library/papers/39895920 | PubMed |
| 11 | 40397261 | SELP can affect the immune microenvironment of gastric cancer and is associated with poor prognosis. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40397261 | PubMed |
| 12 | 34966745 | LncRNAs Target Ferroptosis-Related Genes and Impair Activation of CD4+ T Cell in Gastric Cancer. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34966745 | PubMed |
| 13 | 36050306 | Lactate metabolism in human health and disease. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/36050306 | PubMed |
| 14 | 40102930 | Single-cell RNA sequencing and spatial transcriptomics reveal the heterogeneity and intercellular communication of cancer-associated fibroblasts in gastric cancer. | J Transl Med | 2025 | https://conductscience.org/library/papers/40102930 | PubMed |
| 15 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 16 | 31370155 | Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31370155 | PubMed |
| 17 | 25220842 | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25220842 | PubMed |
| 18 | 35902213 | Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation. | Gut | 2022 | https://conductscience.org/library/papers/35902213 | PubMed |
| 19 | 36483555 | A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients. | Front Immunol | 2022 | https://conductscience.org/library/papers/36483555 | PubMed |
| 20 | 36586241 | Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/36586241 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42404005
GET https://conductscience.org/api/papers/v1/42404005/references?page=2